FDG-PET imaging for the staging and follow-up of small cell lung cancer

European Journal of Nuclear Medicine

Volumn 28, Issue 4, 2001, Pages 483-488

  Schumacher, Tilmann ^a,b   Brink, Ingo ^a   Mix, Michael ^a   Reinhardt, Michael ^a   Herget, Georg ^a   Digel, Werner ^a   Henke, Michael ^a   Moser, Ernst ^a   Nitzsche, Egbert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cancer imaging; Fluorine 18 fluorodeoxyglucose; Positron emission tomography; Radionuclide imaging; Small cell lung cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HUMAN; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LUNG SMALL CELL CANCER; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; CARCINOMA, SMALL CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035094440     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100474     Document Type: Article

References (32)

1. Cancer statistics, 1992
2. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
3. Staging evaluation and prognostic factors in small cell lung cancer
4. Molecular biology of lung cancer
5. Staging of small cell lung cancer
6. Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs
7. Staging, prognostic factors, and special considerations in small cell lung cancer
8. Staging of the patient with small cell lung cancer
9. Imaging lung cancer
10. Simple rapid hydrolysis of acetyl protecting groups in FDG synthesis using cation exchange resins
11. The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification?
12. Accelerated image reconstruction using ordered subsets of projection data
13. PISAC: A post-injection method for segmented attenuation correction in whole-body PET
14. A smoothed EM approach to indirect estimation problems, with particular reference to stereology and emission tomography
15. Combined FDG and [F-18]fluoride whole-body PET: A feasible two-in-one approach to cancer imaging?
16. The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification?
17. Pre-operative staging of non-small-cell lung cancer with positron-emission tomography
18. Bronchogenic carcinoma: Incidence of metastases to normal sized lymph nodes
19. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling
20. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
21. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET
22. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings
23. Contribution of PET in the detection of liver metastases from pancreatic tumours
24. Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-flu-oro-2-deoxy-D-glucose
25. 18F-fluorodeoxy-glucose positron emission tomography
26. Imaging of an adrenal cortex carcinoma and its metastasis with FDG-PET
27. Carbon-11-thymidine and FDG to measure therapy response
28. Multifocal relapse after concurrent chemotherapy and radiotherapy of small cell lung cancer
29. Cisplatin plus oral etopo-side in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group
30. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma
31. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: A decision analysis